FDA-Drug2025-11-05Class II
Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03
ProRx LLC
Hazard
Lack of Assurance of Sterility
Sold states
TX and UT
Affected count
2,761 vials
Manufactured in
619 Jeffers Cir, N/A, Exton, PA, United States
Products
Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-209-03
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0120-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief